Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lab Corp. Amer. (LH) nyse, at $ 2 1/2, exhaustion low ? -- Ignore unavailable to you. Want to Upgrade?

To: rakitup who wrote (53)	3/7/2000 4:26:00 PM
From: hoyasaxa	Read Replies (1) \| Respond to of 62

The 1:10 reverse split noted in the fiscal year end earnings release. If and when the company takes out the preferred and thereby the overhang on the common, I think the stock should do quite well -- note their geno/phenotyping leadership; the recent partnership with Gilead Sciences (via Virco) may be the first of many. I don't hold a position -- but covered the company as a research analyst until 6 months ago (for about three quarters) and dig management. We shall see.....

To: rakitup who wrote (53)	3/8/2000 3:17:00 PM
From: Jim Goodman	Read Replies (1) \| Respond to of 62

thanks for the VG analysis, Don, you may be right....as a rule, my "PSYCLE sm" does not 'pay up', regardless of the potential patterns, fundamentals, stories, etc., but, in recent past years, many which look like LH recently, have broken out for larger % gains over time, good for you.... We try to get the first 100-300 %, with the lowest risk, and move on, when/if stock reaches previous resistance....but we often miss the second 'stage 2 rise' at times, such is life....I am trying to add this 'buy higher for potential stage 3' idea, so thanks....will try to stay in touch, best wishes,